Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | REN | P00797 | 6/20 | 0.46 |
| ▸ | CTSL | P07711 | 6/20 | 0.42 |
| ▸ | NMBR | P28336 | 1/20 | 0.41 |
| ▸ | CASP3 | P42574 | 1/20 | 0.41 |
| ▸ | CTSS | P25774 | 1/20 | 0.40 |
| ▸ | CTSB | P07858 | 2/20 | 0.40 |
| ▸ | CTSK | P43235 | 1/20 | 0.40 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10757999 | 0.95 | REN (0.43) | RENCTSLNMBRCASP3CTSS | |
| SCHEMBL7277008 | 0.89 | REN (0.46) | RENCTSLCASP3CTSSCTSB | |
| SCHEMBL7286074 | 0.88 | CTSL (0.42) | RENCTSLNMBRCASP3CTSS | |
| SCHEMBL10718460 | 0.84 | REN (0.47) | RENCTSLNMBRCASP3CTSS | |
| SCHEMBL10716091 | 0.84 | REN (0.44) | RENCTSLCASP3CTSSCTSB | |
| SCHEMBL10715808 | 0.82 | CTSL (0.44) | RENCTSLNMBRCASP3CTSS | |
| SCHEMBL10762553 | 0.82 | CTSL (0.45) | RENCTSLNMBRCASP3CTSS | |
| SCHEMBL10718613 | 0.82 | CTSL (0.45) | RENCTSLCASP3CTSSCTSB | |
| SCHEMBL7286352 | 0.81 | CTSL (0.44) | RENCTSLCASP3CTSSCTSB | |
| SCHEMBL10718584 | 0.81 | REN (0.46) | RENCTSLNMBRCASP3CTSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0209848-A2 | Enzyme inhibitors | MERCK & CO. INC. (US) | 1987-01-28 | — | — | EP | claimed |
| EP-0209848-A2 | Enzyme inhibitors | MERCK & CO. INC. (US) | 1987-01-28 | — | — | EP | disclosed |